Perceive Biotherapeutics

CompanyUnited States

Perceive Biotherapeutics develops one asset, in phase 2 (VOY-101 in geographic atrophy). Mostly gene therapy; based in the United States.

1
Asset
Furthest stage
Phase 2
0
Trials
1
Signal

Pipeline

1
  • VOY-101

    Phase 2, Gene therapy, geographic atrophy

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Signals1
  • Similar companies6

Intelligence